Breaking News

Over a week ago Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
EXPO Exponent $50.35 (0.00%) 08:34 07/20/18 07/20 08:34 07/20/18 08:34 Recommendations	Exponent analyst commentary at SunTrust » Exponent price target… Exponent price target raised to $56 from $47.50 at SunTrust. SunTrust analyst Tobey Sommer raised his price target on Exponent to $56 after its Q2 earnings beat along with its raised EBITDA margin guidance. Sommer says the "industry-focused sale teams" are driving market share gains in the "lucrative large proactive engagements", while the company's new CEO Catherine Corrigan also offered "crisp" and "insightful" answers on the earnings call. The analyst is keeping his Buy rating on Exponent, stating the company's underlying growth remains firm, while its focus on "cross-selling by forming industry-focused sales teams" should also allow it to capture market share. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Aug

Over a month ago
EXPO Exponent $50.45 0.1 (0.20%) 16:08 07/19/18 07/19 16:08 07/19/18 16:08 Earnings	Exponent reports Q2 EPS 34c, consensus 31c » Reports Q2 revenue… Reports Q2 revenue $95.6M, consensus $92.75M. Exponent's tax rate decreased to 26.1% in Q2, as compared to 38.3% in same period last year, due to the new tax legislation. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Jul 06 Aug
EXPO Exponent $98.40 -0.7 (-0.71%) 16:20 05/31/18 05/31 16:20 05/31/18 16:20 Hot Stocks	Exponent announces Catherine Corrigan as CEO » Exponent announced that… Exponent announced that its board appointed Catherine Corrigan as its CEO and president, and Paul Johnston, 64, as its executive chairman at its board meeting on May 31. Additionally, John Shoven, was appointed lead independent director. These changes are consistent with the executive transition plan previously announced on December 7, 2017. Corrigan joined Exponent 21 years ago and has assumed increasingly responsible positions over time. Most recently as president, she was responsible for management of all the company's consulting groups and business development activities. She was previously group VP of the transportation group and joined the company's operating committee in 2012. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May

Over a quarter ago
EXPO Exponent $91.85 0.725 (0.80%) 16:11 05/15/18 05/15 16:11 05/15/18 16:11 Hot Stocks	Exponent announces two-for-one stock split » Exponent announced that… Exponent announced that its board has approved a two-for-one stock split of its common stock and a change in the number of authorized shares of common stock to 120M, each subject to stockholder approval of both the split and the change in authorized shares at the 2018 annual meeting of stockholders on May 31. If Exponent's stockholders approve the stock split and the change in authorized shares, each stockholder of record at the close of business on May 31 will receive one additional share of common stock for every outstanding share of common stock held on the record date. Upon completion of the stock split, Exponent will have approximately 52M shares of common stock outstanding. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
EXPO Exponent $85.95 1.35 (1.60%) 08:42 04/23/18 04/23 08:42 04/23/18 08:42 Recommendations	Exponent analyst commentary at SunTrust » Exponent price target… Exponent price target raised to $95 from $84 at SunTrust. SunTrust analyst Tobey Sommer raised his price target on Exponent to $95, saying he is encouraged by the company's Q1 earnings beat and its positive FY18 outlook. Sommer notes that the company's upgrade in its FY18 EBITDA margin view is driven by "robust demand levels from various industries", including consumer products, automotive, medical products, and energy. The analyst keeps his Buy rating, also citing the company's expansion into the "more lucrative" proactive services business. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

EXPO Exponent $84.60 -0.25 (-0.29%) 16:12 04/19/18 04/19 16:12 04/19/18 16:12 Hot Stocks	Exponent sees FY18 revenue up mid-to high-single digits before reimbursements » "Our outlook… "Our outlook reflects positive momentum in the business, as well as the expected deceleration of the ongoing human factors assessment project in 2018. We are improving our expectations for the full year 2018. We now expect revenues before reimbursements to grow in the mid- to high- single digits and EBITDA margin to decline by approximately 50 to 100 basis points, as compared to 2017. As previously discussed, we continue to believe that Exponent's consolidated income tax rate will be approximately 22% to 23% for 2018, after including the estimated tax adjustments associated with share-based awards. This tax rate range is approximately ten percentage points lower than it would have been as a result of the new Tax Legislation," commented Richard Schlenker, Executive Vice President and CFO. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Apr
EXPO Exponent $84.65 -0.2 (-0.24%) 16:08 04/19/18 04/19 16:08 04/19/18 16:08 Earnings	Exponent reports Q1 EPS 75c, consensus 62c » Reports Q1 revenue… Reports Q1 revenue $96.5M, consensus $89.51M 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Apr
EXPO Exponent $75.20 1.05 (1.42%) 16:13 02/01/18 02/01 16:13 02/01/18 16:13 Earnings	Exponent sees FY18 revenue growth in mid-single digits » Exponent sees FY18… Exponent sees FY18 revenues before reimbursements to grow in the mid-single digits and EBITDA margin to decline by approximately 100 to 150 basis points, as compared to 2017. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 Feb
EXPO Exponent $75.20 1.05 (1.42%) 16:11 02/01/18 02/01 16:11 02/01/18 16:11 Earnings	Exponent reports Q4 EPS 47c, consensus 42c » Reports Q4 revenue… Reports Q4 revenue $88.28M, consensus $83.58M. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 Feb
EXPO Exponent $75.20 1.05 (1.42%) 16:09 02/01/18 02/01 16:09 02/01/18 16:09 Hot Stocks	Exponent increases quarterly dividend to 26c per share from 21c per share » Exponent announced that… Exponent announced that its board has declared an increased quarterly cash dividend of 26c per share of common stock to be paid on March 23 to all common stockholders of record as of March 2. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 Feb

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial